2

What are the best treatments for Acute myelogenous leukemia (AML)?

See the best treatments for Acute myelogenous leukemia (AML) here

Acute myelogenous leukemia (AML) treatments

Treatments for Acute Myelogenous Leukemia (AML)


Acute Myelogenous Leukemia (AML) is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells. AML requires prompt and aggressive treatment to achieve remission and improve survival rates. The choice of treatment depends on several factors, including the patient's age, overall health, and specific genetic mutations present in the leukemia cells.



Chemotherapy


Chemotherapy is the primary treatment for AML. It involves the use of powerful drugs to kill cancer cells and prevent their further growth. Chemotherapy can be administered in different ways, including intravenous infusion, oral medications, or injections. The treatment is typically divided into two phases: induction and consolidation.


Induction chemotherapy aims to achieve remission by rapidly reducing the number of leukemia cells in the bone marrow and blood. This phase usually lasts for several weeks and requires hospitalization. The specific drugs used may vary, but common regimens include cytarabine and an anthracycline drug, such as daunorubicin or idarubicin.


Consolidation chemotherapy follows induction and aims to eliminate any remaining leukemia cells that may not be detectable. This phase helps to prevent relapse and improve long-term outcomes. Consolidation therapy may involve high-dose chemotherapy, stem cell transplantation, or additional cycles of chemotherapy.



Targeted Therapy


Targeted therapy is a newer approach that focuses on specific genetic mutations or abnormalities present in leukemia cells. These drugs work by interfering with the signaling pathways that promote cancer cell growth and survival. Some targeted therapies approved for AML include:



  • FLT3 inhibitors: Drugs like midostaurin and gilteritinib target the FLT3 mutation, which is present in about one-third of AML patients.

  • IDH inhibitors: Enasidenib and ivosidenib target the IDH1 and IDH2 mutations, respectively, found in a subset of AML patients.

  • BCL-2 inhibitors: Venetoclax, in combination with chemotherapy, is used to treat AML patients with the BCL-2 mutation.


Targeted therapies are often used in combination with chemotherapy or as maintenance therapy after achieving remission. They offer a more precise and potentially less toxic treatment option for certain AML patients.



Stem Cell Transplantation


Stem cell transplantation, also known as a bone marrow transplant, may be recommended for certain AML patients. It involves replacing the diseased bone marrow with healthy stem cells from a donor. This procedure allows for the regeneration of normal blood cells and can be curative for some patients.


There are two main types of stem cell transplantation:



  • Autologous transplant: The patient's own stem cells are collected and stored before high-dose chemotherapy. After chemotherapy, the stored stem cells are returned to the patient to help rebuild the bone marrow.

  • Allogeneic transplant: Stem cells are obtained from a compatible donor, often a sibling or unrelated matched donor. The donor cells are then infused into the patient after high-dose chemotherapy.


Stem cell transplantation carries risks and requires careful consideration of factors such as age, overall health, and availability of a suitable donor. It is typically reserved for younger patients and those with high-risk AML.



Supportive Care


In addition to the specific treatments mentioned above, supportive care plays a crucial role in managing AML. Supportive care aims to prevent and manage complications, relieve symptoms, and improve the patient's overall well-being. It may include:



  • Transfusions: Red blood cell and platelet transfusions may be necessary to manage anemia and bleeding tendencies.

  • Growth factors: Medications such as granulocyte colony-stimulating factor (G-CSF) can stimulate the production of white blood cells.

  • Antibiotics: Prophylactic or therapeutic antibiotics may be prescribed to prevent or treat infections, which are common in AML patients with compromised immune systems.

  • Antifungal and antiviral medications: These may be used to prevent or treat fungal and viral infections.

  • Pain management: Adequate pain relief is essential and can be achieved through various medications and supportive measures.

  • Psychosocial support: AML treatment can be physically and emotionally challenging. Counseling, support groups, and other psychosocial interventions can help patients and their families cope with the impact of the disease.


It is important for AML patients to have a comprehensive care team that includes oncologists, hematologists, nurses, and other healthcare professionals to provide the necessary support throughout the treatment journey.



In conclusion, the treatment of Acute Myelogenous Leukemia (AML) involves a combination of chemotherapy, targeted therapy, stem cell transplantation, and supportive care. The specific treatment plan is tailored to each patient based on their individual characteristics and disease factors. Advances in targeted therapies have provided additional treatment options for certain genetic mutations, improving outcomes for some AML patients. Ongoing research and clinical trials continue to explore new treatment strategies and improve the overall management of AML.


Diseasemaps
2 answers
Translated from spanish Improve translation
What determines the doctor for each patient

Posted Sep 11, 2017 by cecilia verónica 900

Acute myelogenous leukemia (AML) treatments

Acute myelogenous leukemia (AML) life expectancy

What is the life expectancy of someone with Acute myelogenous leukemia (AML...

2 answers
Celebrities with Acute myelogenous leukemia (AML)

Celebrities with Acute myelogenous leukemia (AML)

1 answer
Is Acute myelogenous leukemia (AML) hereditary?

Is Acute myelogenous leukemia (AML) hereditary?

2 answers
Is Acute myelogenous leukemia (AML) contagious?

Is Acute myelogenous leukemia (AML) contagious?

2 answers
Natural treatment of Acute myelogenous leukemia (AML)

Is there any natural treatment for Acute myelogenous leukemia (AML)?

1 answer
ICD9 and ICD10 codes of Acute myelogenous leukemia (AML)

ICD10 code of Acute myelogenous leukemia (AML) and ICD9 code

2 answers
Living with Acute myelogenous leukemia (AML)

Living with Acute myelogenous leukemia (AML). How to live with Acute myelog...

1 answer
Acute myelogenous leukemia (AML) diet

Acute myelogenous leukemia (AML) diet. Is there a diet which improves the q...

1 answer

World map of Acute myelogenous leukemia (AML)

Find people with Acute myelogenous leukemia (AML) through the map. Connect with them and share experiences. Join the Acute myelogenous leukemia (AML) community.

Stories of Acute myelogenous leukemia (AML)

ACUTE MYELOGENOUS LEUKEMIA (AML) STORIES
Acute myelogenous leukemia (AML) stories
in 2014, i started having bone pain in my legs from the knees down. That then went into my hips, but only was painfull at night. I would wake up the next day as a normal guy my age. I blew it off as old age, and doing to much. It kept getting worse a...

Tell your story and help others

Tell my story

Acute myelogenous leukemia (AML) forum

ACUTE MYELOGENOUS LEUKEMIA (AML) FORUM

Ask a question and get answers from other users.

Ask a question

Find your symptoms soulmates

From now on you can add your symptoms in diseasemaps and find your symptoms soulmates. Symptoms soulmates are people with similar symptoms to you.

Symptoms soulmates

Add your symptoms and discover your soulmates map

Soulmates map